Health Anxiety From the Pandemic Initiative

Study acronym: HAPI
StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
3,284 trials monitored
See 154 trials at risk
The COVID-19 pandemic intensified health anxiety, a common and costly condition marked by excessive fear of illness and functional impairment. Despite growing prevalence and impact, health anxiety remains under-recognized in clinical practice. Scalable, accessible interventions such as internet-based cognitive behavioral therapy (iCBT) are needed to address this gap. A three-arm randomized controlled trial with a waitlist control group was conducted to evaluate two self-guided digital interventions for health anxiety: THIS WAY UP iCBT and 90SecondHealth Anxiety compared to a control group. Canadian adults meeting eligibility criteria were randomized (1:1:1). Assessments occurred at baseline, post-intervention, and at one- and three-month follow-ups. Primary outcomes were health anxiety, depression, and generalized anxiety.
Trial Details
NCT Number NCT07867483
Lead Sponsor IWK Health Centre
Conditions
(from sponsor)
Health Anxiety
Enrollment 278 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov